A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma
This study has been completed.
Study NCT00647101
Information provided by Pfizer
First Received on March 26, 2008.
Last Updated on March 28, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
